Adrian G. Sacher

机构：University Health Network, University of Toronto, Princess Margaret Cancer Centre · ORCID：0000-0001-7865-2701

发表论文 403 篇 · 总被引 9871 次 · h-index 42

代表论文

• Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study (2025 · Annals of Oncology · 被引 43)
• Single-Agent Divarasib in Patients With KRAS G12C –Positive Non–Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study (2025 · Journal of Clinical Oncology · 被引 28)
• Lung Cancer and Cardiovascular Disease (2025 · JACC CardioOncology · 被引 13)
• Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLC (2025 · Journal of Thoracic Oncology · 被引 7)
• Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study (2026 · Nature Communications · 被引 6)
• Modeling response to the KRAS-G12C inhibitor AZD4625 in KRASG12C NSCLC patient-derived xenografts reveals insights into primary resistance mechanisms (2025 · British Journal of Cancer · 被引 2)